MedTech Innovator Asia Pacific 2024 Impact Report: What You Need to Know

MedTech Innovator Asia Pacific is making significant strides in transforming the healthcare landscape through its impactful programs designed to accelerate the growth of innovative medtech companies. The organization’s 2024 Impact Report highlights the success of its core initiatives, the APAC Accelerator Program and the Singapore – U.S. Market Access Program, and their substantial contribution to the region’s MedTech ecosystem.

APAC Accelerator Program: Nurturing Innovation and Growth

The APAC Accelerator Program serves as a cornerstone of MedTech Innovator Asia Pacific‘s efforts to support startups in the medical device, diagnostic, and digital health sectors. This flagship program connects high-potential startups with expert mentorship, a global network, and high-profile exposure to investors and industry leaders.

In 2024, the APAC Accelerator Program provided a 4-month intensive program for 20 startups, with the support of 52 mentors and coaches. The program boasts impressive engagement, with over 400 total applications received, resulting in a highly competitive 5% acceptance rate. The program’s effectiveness is further demonstrated by the fact that 45% of the participating startups are revenue-generating.

The program’s comprehensive curriculum covers crucial areas such as fundraising, pitching, corporate partnerships, legal and compliance, and commercialization. Startups receive personalized guidance and access to tailored educational webinars, empowering them to refine their strategies and maximize their potential.

Singapore – U.S. Market Access Program: Facilitating Global Expansion

Recognizing the importance of market access for startups, MedTech Innovator Asia Pacific launched the Singapore – U.S. Market Access Program. Supported by Enterprise Singapore, this 7-month intensive program provides Singaporean companies with the knowledge, strategies, and ongoing support needed for successful expansion into the U.S. market.

The program focuses on key activities such as market readiness assessment, value workshops and coaching, and one-on-one corporate mentorship. In its inaugural year, the program facilitated over 150 business matches and meetings, demonstrating its effectiveness in connecting startups with valuable opportunities.

Driving Success and Achieving Milestones

MedTech Innovator Asia Pacific’s programs have played a pivotal role in the success of numerous startups. The 2024 cohort has achieved significant milestones, including:

Qritive‘s partnership with Roche to integrate their AI tools with Roche’s navify® Digital Pathology platform, enhancing diagnostic precision and speeding up reporting times.

VinBrain’s acquisition by NVIDIA, recognizing their groundbreaking work in AI-driven medical imaging for disease diagnosis.

Thrixen raising USD 7M in funding to accelerate the development of their diagnostic technology platform.

Aevice Health securing USD 7M in a Seed Plus round to support the expansion of their wearable stethoscopes into key markets.

These achievements underscore the transformative impact of MedTech Innovator Asia Pacific’s programs in driving innovation and facilitating the growth of promising MedTech companies.

MedTech Malta 2025

MedTech Malta 2025 is set to take place from 12 to 14 November in Valletta, bringing together innovators, investors, and professionals at the forefront of healthcare and medical technology. Whether you’re a startup founder seeking funding, a MedTech expert eager to connect with peers, or someone looking to stay informed on emerging trends, the event offers a practical and engaging space to get involved. From thought-provoking panels and hands-on networking to opportunities like speaker slots, sponsorship packages, and the MedTech Startup Pitch Competition, there’s something for everyone. To explore how you can participate, reach out to [email protected]. Early bird tickets are now available—secure yours today at the lowest price before they’re gone.